MarketPeel
Insider Trading Intelligence
CH

Cristin Hubbard

BMRN
EVP, CHIEF COMMERCIAL OFFICER · BIOMARIN PHARMACEUTICAL INC · CIK 0002021836
FILING MIX · LIFETIME67%/33%
BUYS
8
SELLS
4
TOTAL VALUE
$347.8K
COMPANIES
1
ACTIVE SINCE
May 2024
HOLDINGS NOW
42,472
AVG SELL PX
$55.59
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Cristin Hubbard, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-5.11%-0.43%-4.68%-4.68%
14d1+100.00%-4.45%+4.84%-9.29%-9.29%
30d1+100.00%-8.03%+4.58%-12.61%-12.61%
60d1+100.00%-9.41%+8.98%-18.39%-18.39%
90d1+100.00%-6.74%+11.53%-18.26%-18.26%
180d1+100.00%-16.39%+21.28%-37.68%-37.68%
1y1+100.00%-12.85%+27.15%-40.00%-40.00%
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BMRN · 42,472 shares · as of May 20, 2026
011,50923,01834,52646,03520252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 4 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BMRN
BIOMARIN PHARMACEUTICAL INC
SALE
EVP, Chief Commercial Officer
2,318$50.20$116.4K42,472May 20, 2026May 21, 2026View →
BMRN
BIOMARIN PHARMACEUTICAL INC
SALE
EVP, Chief Commercial Officer
1,245$56.05$69.8K44,790Mar 17, 2026Mar 18, 2026View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
36,68036,680Mar 16, 2026Mar 18, 2026View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
15,41046,035Mar 16, 2026Mar 18, 2026View →
BMRN
BIOMARIN PHARMACEUTICAL INC
SALE
EVP, Chief Commercial Officer
2,155$59.93$129.1K30,545May 20, 2025May 22, 2025View →
BMRN
BIOMARIN PHARMACEUTICAL INC
SALE10b5-1
10b5-1 plan
273$64.92$17.7K32,700May 2, 2025May 6, 2025View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
273$54.14$14.8K32,973Apr 30, 2025May 6, 2025View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
13,31032,700Mar 17, 2025Mar 18, 2025View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
30,88030,880Mar 17, 2025Mar 18, 2025View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
4,70019,390May 20, 2024May 22, 2024View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
14,69014,690May 20, 2024May 22, 2024View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
33,52033,520May 20, 2024May 22, 2024View →
Other insiders · BMRN
Loading peer insiders…
About this filer
CIK 0002021836
ROLE
EVP, Chief Commercial Officer
PRIMARY
BMRN
COMPANIES
1
ACTIVE SINCE
May 2024
MARKETPEEL · /INSIDER/0002021836DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback